First‐in‐human use of a new robotic electromagnetic navigation bronchoscopic platform with integrated Tool‐in‐Lesion Tomosynthesis (TiLT) technology for peripheral pulmonary lesions: The FRONTIER study.

MLA

Saghaie, Tajalli, et al. “First‐in‐human Use of a New Robotic Electromagnetic Navigation Bronchoscopic Platform with Integrated Tool‐in‐Lesion Tomosynthesis (TiLT) Technology for Peripheral Pulmonary Lesions: The FRONTIER Study.” Respirology, vol. 29, no. 11, Nov. 2024, pp. 969–75. EBSCOhost, https://doi.org/10.1111/resp.14778.

APA

Saghaie, T., Williamson, J. P., Phillips, M., Kafili, D., Sundar, S., Hogarth, D. K., & Ing, A. (2024). First‐in‐human use of a new robotic electromagnetic navigation bronchoscopic platform with integrated Tool‐in‐Lesion Tomosynthesis (TiLT) technology for peripheral pulmonary lesions: The FRONTIER study. Respirology, 29(11), 969–975. https://doi.org/10.1111/resp.14778

Chicago

Saghaie, Tajalli, Jonathan P. Williamson, Martin Phillips, Dona Kafili, Sarika Sundar, D. Kyle Hogarth, and Alvin Ing. 2024. “First‐in‐human Use of a New Robotic Electromagnetic Navigation Bronchoscopic Platform with Integrated Tool‐in‐Lesion Tomosynthesis (TiLT) Technology for Peripheral Pulmonary Lesions: The FRONTIER Study.” Respirology 29 (11): 969–75. doi:10.1111/resp.14778.